Isadora Silva Fanucci Bueno

Isadora Silva Fanucci Bueno

Auto-generated profile, based on publicly available information

Isadora Silva Fanucci Bueno

Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo - SP, Brazil

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2025 in Jornal de Pediatria
Verified
Journal Article
Open access
LCLuís Fernando Ferreira Cavalcante
Luís Fernando Ferreira Cavalcante
GCGiovanna Costa
Giovanna Costa
SBSophia Massafelli Battistuta
Sophia Massafelli Battistuta
PMPedro Faria Makabe
Pedro Faria Makabe
IBIsadora Silva Fanucci Bueno
Isadora Silva Fanucci Bueno
MSMarco Aurelio Palazzi Safadi
Marco Aurelio Palazzi Safadi
This systematic review and meta-analysis aimed to evaluate the efficacy of surgical management, specifically total and partial tonsillectomy, for Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) syndrome, focusing on symptom resolution and recurrence reduction. A systematic search of MEDLINE, Scopus, and Cochrane databases identified randomized controlled trials (RCTs) comparing surgical to non-surgical management in children with PFAPA. Data extraction and quality assessment adhered to Cochrane guidelines and PRISMA protocols. Risk ratios (RR) and confidence intervals (CI) were calculated using random-effects models. After the removal of duplicates, 31 studies were screened and 3 studies were included. Pooled analysis revealed a 72% reduction in persistent symptoms following surgical interventions compared to non-surgical management (RR: 0.28, 95% CI: 0.12-0.68, I² = 22%, p = 0.005). The findings confirm that surgical management, including total and partial tonsillectomy, is an effective therapeutic option for PFAPA, with substantial benefits in symptom resolution and quality of life improvement. While surgery offers long-term benefits, its risks, and broader immunological implications require careful consideration. The study underscores the necessity for larger, multicenter trials to validate these findings across diverse populations and optimize treatment strategies.

1 December 2025 in Neurology Clinical Practice
Verified
Journal Article
Closed access
GCGiovanna Ristori Costa
Giovanna Ristori Costa
LCLuís Fernando Ferreira Cavalcante
Luís Fernando Ferreira Cavalcante
SBSophia Massafelli Battistuta
Sophia Massafelli Battistuta
PMPedro Faria Makabe
Pedro Faria Makabe
IBIsadora Silva Fanucci Bueno
Isadora Silva Fanucci Bueno
Diogo Haddad SantosDiogo Haddad Santos
Diogo Haddad Santos

7 May 2026 in BMC Urology
Verified
Journal Article
Open access
PDF file
PMPedro Faria Makabe
Pedro Faria Makabe
LCLuís Fernando Ferreira Cavalcante
Luís Fernando Ferreira Cavalcante
BYBruno Yuamoto
Bruno Yuamoto
SBSophia Massafelli Battistuta
Sophia Massafelli Battistuta
GCGiovanna Ristori Costa
Giovanna Ristori Costa
LTLuis Gustavo Morato de Toledo
Luis Gustavo Morato de Toledo
Tranexamic acid (TXA) is an antifibrinolytic agent with demonstrated benefits in various surgical procedures, including urological surgeries. However, its